Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN® (epinephrine in 0.9% sodium ...
Profs Ravi Acharya and Edward Sturrock review the historical foundation, present landscape and future clinical promise of ACE inhibition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback